On Oct 25,2018, Duopharma Biotech had acquired a 5.8% stake in SCM Lifescience for 5.5 billion won or RM20.24mil.
KUALA LUMPUR: Duopharma Biotech Bhd
’s investee company, SCM Lifescience Co Ltd has been listed on Kosdaq, which is a trading board of Korea Exchange in South Korea.
SCM Lifescience specialises in stem cell therapeutics with proprietary platform technology in the field of high-purity isolation and cultivation of mesenchymal stem cells and is currently focusing on autoimmune diseases.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
